The intranasal Covid vaccine to be introduced in the COVID-19 vaccination program from today
The Centre on Friday approved Bharat Biotech‘s needle-free intranasal Covid vaccine for a booster dose, said an official source. The nasal vaccine will likely be added to the CoWIN App from this day only.
The nasal vaccine has been approved for those aged above 18 years. The vaccine will be available in private hospitals for booster doses in the initial phase.
The source said the nasal vaccine will be used as a heterologous booster among the eligible population. Meanwhile, the source also expects the intranasal Covid vaccine to be introduced in the COVID-19 vaccination program from Friday.
Meanwhile, India on Friday reported 163 fresh COVID-19 cases along with nine deaths have also been reported in the country. The number of active Coronavirus cases declined to 3,380.
China is currently seeing a surge in COVID-19 cases and is imposing forced lockdowns. Meanwhile, India proacts and gears up to fight a potential resurgence of the Covid virus.
[With Inputs from IANS]
PGurus is now on Telegram. Click here to join our channel and stay updated with all the latest news and views
For all the latest updates, download PGurus App.
- CBI raids Sheikh Shahjahan’s relative in Sandeshkhali; seizes huge cache of arms, explosives - April 26, 2024
- Will ‘exit India’ if forced to break encryption: WhatsApp to Delhi High Court - April 26, 2024
- Seers of Ayodhya react sharply to Rahul, Priyanka’s ‘proposed’ visit to Shri Ram Mandir - April 26, 2024
Export to Taiwan. Let Chinese citizens believing Indian vaccine effectiveness to take jabs in Taiwan and those Chinese will spread Indian message within China
Can we export Indian vaccines to China as part of Vasudev Kutumb ?